Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4636583
Max Phase: Preclinical
Molecular Formula: C23H35N5O7S
Molecular Weight: 525.63
Molecule Type: Unknown
Associated Items:
ID: ALA4636583
Max Phase: Preclinical
Molecular Formula: C23H35N5O7S
Molecular Weight: 525.63
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC(C)[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1OC[C@@H](CCCn2cc(-c3ccccc3)nn2)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C23H35N5O7S/c1-3-15(2)20(24)23(31)26-36(32,33)35-14-19-22(30)21(29)17(13-34-19)10-7-11-28-12-18(25-27-28)16-8-5-4-6-9-16/h4-6,8-9,12,15,17,19-22,29-30H,3,7,10-11,13-14,24H2,1-2H3,(H,26,31)/t15?,17-,19-,20+,21+,22-/m1/s1
Standard InChI Key: DNOFFMHVFVIEIH-JBWXAVFGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 525.63 | Molecular Weight (Monoisotopic): 525.2257 | AlogP: 0.21 | #Rotatable Bonds: 12 |
Polar Surface Area: 178.89 | Molecular Species: ACID | HBA: 11 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.74 | CX Basic pKa: 6.88 | CX LogP: 0.19 | CX LogD: 0.14 |
Aromatic Rings: 2 | Heavy Atoms: 36 | QED Weighted: 0.30 | Np Likeness Score: -0.08 |
1. De Ruysscher D, Pang L, Mattelaer CA, Nautiyal M, De Graef S, Rozenski J, Strelkov SV, Lescrinier E, Weeks SD, Van Aerschot A.. (2020) Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase., 28 (15): [PMID:32631562] [10.1016/j.bmc.2020.115580] |
Source(1):